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A  synthetic  N-acetylmuramyl-L-alanyl-D-isoglutamine,  or  muramyl  dipeptide 
(MDP), is known to be a minimal effective structure for adjuvant activity of cell wall 
peptidoglycans (1-3). MDP-stimulated maerophages release monokines or interleukin 
1 (IL-1) that are mainly concerned with the activation of T  cells  (4-8). 
Recently, Luger et al.  (9,  10)  described a  cytokine, epidermal cell-derived thymo- 
cyte-activating factor that  is  biologically and  biochemically similar  to  IL-1.  More 
recently,  Fontana  et  al.  (11)  also  demonstrated  a  IL-l-like  factor  derived  from 
astrocytes and glioma cells stimulated with lipopolysaccharide. Okai et al. (12) showed 
that  murine  3T3  fibroblasts stimulated  with  12-O-tetradecanoyl-phorbol-13-acetate 
(TPA) produced soluble factors that augment the proliferative response of thymocytes 
to  concanavalin  A.  These  findings  suggest  that  epidermal  cells,  astrocytes,  and 
fibroblasts interact with the immune system by elaborating nonspecific factors. 
In  the  present  study,  we show that  MDP could stimulate  skin  fibroblasts of the 
guinea pig to  produce thymocyte-activating factor.  Furthermore,  using four MDP 
analogues that were shown to be adjuvant-active or -inactive (3), we found a striking 
parallelism between adjuvant activity of these compounds and the stimulating effect 
on  the  production  of thymocyte-activating factor from fibroblasts.  The  fibroblast- 
derived factor was also shown to be distinct from T  cell growth factor (TCGF) or T 
cell-activating monokines. 
Materials and Methods 
Animals.  Inbred strain  2 and JY-1  guinea  pigs that were  1-2 mo old were used. Strain  2 
guinea pigs were obtained  from  Nisseiken Co.,  Ltd.,  Tokyo, Japan. JY-1  guinea pigs were 
kindly supplied  from the National  Institute of Health (Japan).  These guinea pigs were bred in 
this laboratory. 
Fibroblast Cultures.  Skin fibroblasts  were prepared  as described  by Wahl et  al.  (13). Skin 
explants  from strain  2 or JY-1 guinea pigs were placed in 21-cm  2 tissue culture  dishes (Falcon 
Labware, Div. Becton, Dickinson and Co., Oxnard, CA) and the fibroblasts grown to confluency 
in  Dulbecco's  modified  Eagle's  medium  (DME)  (Gibco  Laboratories,  Grand  Island,  NY) 
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supplemented with  10% heat-inactivated fetal calf serum (FCS), 7 mM Hepes (Doujin Yaku- 
kagakt~ Institute, Japan), 50 U/ml of penicillin, and 50/~g/ml of streptomycin. These primary 
fibroblasts were maintained in culture at 37°C in  10% CO2 and subcuhured by treatment of 
Bacillus polymixa  protease, 1,000 U/ml of Dispase (Godoshusei Co., Ltd., Japan). The fibroblasts 
between  two  and  four  passages were  used  in  the  following experiments.  These  fibroblasts 
consisted of >99% fibroblasts, as morphologically determined by a phase contrast microscope, 
and <_--0.5% nonspecific esterase-positive cells. 
Culture Supernatants of Fibroblasts Stimulated with MDP or its Analogues.  The confluent cultured 
fibroblasts (0.8-1 ×  106 cells in 5 ml/dish) were washed once with Hank s balanced salt solution 
(HBSS) and refilled with fresh DME. The culture were added with MDP or its analogues at 
various concentrations and  cultured for  72  h.  MDP  and  its analogues were synthesized as 
described previously  (14).  The  synthetic  MDP  was  kindly provided by  Dr.  Atsuro  Inoue 
(Daiichi Pharmaceutical Co., Tokyo) or purchased from Protein Research Foundation, Osaka. 
The culture supernatants were collected by centrifugation (200 g,  10  rain and  10,000 g,  30 
rain). The culture supernatants of fibroblasts incubated without MDP or its analogues were 
supplemented  with  these  compounds  at  the  end  of the  culture  and  served  as  the  control 
supernatants. These culture supernatants were dialyzed three times against HBSS, and finally 
against tissue culture medium 199 (Chiba-ken Serum Inst., Chiba, Japan) and filtered through 
a membrane filter (pore size, 0.45/xm; Sartorius, G~ttingen, West Germany). 
Proliferative Response of Thymocytes to PHA.  Thymocytes of the guinea pig were suspended at 
5 ×  i0  celis/ml in tissue culture medium 199 supplemented with 5% FCS, 7 mM Hepes, 5 × 
10  -s M  2-mercaptoethanol, 50 U/ml penicillin, and 50/zg/ml streptomycin. Thymocytes (1 × 
106 cells/0.25 ml) were added with phytohemagglutinin (PHA-P, Difco Laboratories, Detroit, 
MI)  (2 #g/ml) and cultured in flat-bottomed Falcon Microtest II tissue culture plates in  10% 
(202 in air for 72 h. The culture supernatants of fibroblasts were added to the cultures at 20% 
(vol/vol) concentration. The cultures were pulsed with 0.2/~Ci tritiated thymidine ([aH]TdR, 
5  Ci/nmol,  RCC,  Amersham,  England)  for  the  final  18  h  of incubation.  The  [aH]TdR 
incorporation was measured as described previously (7). The data are expressed as the arithmetic 
mean of cpm :1: standard error of triplicate culture. 
Fractionation of the Culture Supernatant  on a Sephac~yl S-200 Column.  The culture supernatant 
(200 ml) of fibroblasts stimulated with MDP at 5 #g/ml was concentrated and fractionated on 
a  Sephacryl S-200 column (Z6 ×  89 cm) in 0.5 M  NaCI, 0.1  M  Tris-HC1 buffer at pH 8.0. 
Each fraction was dialyzed against HBSS and finally against medium 199, and filtered through 
a membrane filter. 
TCGF Activity.  TCGF  activity of the  culture  supernatants  was  measured  as  described 
previously (15). Briefly, PHA-activated lymphoblasts (5 ×  104 cells/0.25 ml/well) were cultured 
with or without the culture supernatants in the presence of 0.2/LCi of [aH]TdR for 24 h. The 
cells were harvested and assayed for the incorporation of [aH]TdR as described previously (7). 
Results 
The confluent-cultured fibroblasts were stimulated with MDP  at varying concen- 
trations (0.001-50 ~g/ml) and the culture supernatants were tested for an augmenting 
effect on the proliferative response of thymocytes to PHA. As shown in Table I, the 
culture  supernatants  of fibroblasts incubated  without  MDP  slightly enhanced  the 
proliferation of thymocytes to PHA. The culture supernatants of flbroblasts stimulated 
with MDP  at concentrations of 1-50/~g/ml exhibited marked thymocyte-activating 
activity. The control culture supernatant  of fibroblasts supplemented with  MDP  at 
the  end  of culture  exhibited,  after  dialysis, as  low  activity  as  the  supernatant  of 
flbroblasts cultured  without  MDP  (data  not  shown).  The  culture  supernatant  of 
fibroblasts stimulated with  MDP  did not  induce the proliferation of thymocytes in 
the absence of PHA  (see footnote to Table I). 
The culture supernatants of fibroblasts stimulated with MDP analogues were tested 
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TABLE I 
Production of Thymocyte-activating Factor  from Fibroblasts 
Stimulated with MDP 
Culture supernatants added to the culture  Proliferative response  of thy- 
mocytes to PHA* 
cpm ± SE 
None  8,320 ±  201 
Fibroblasts  11,860 ±  966 
Fibroblasts stimulated with MDP at 
0.001 ~g/ml  12,503 ±  232 
0.01  13,027 ±  1,792 
0.1  16,945 ±  884 
1.0  24,650 ±  233 
10.0  24,969 ±  1,748 
50.0  23,522 ±  433 
* Thymocytes  cultured without PHA incorporated 283 ±  73 cpm of[nH]TdR. Thymocytes 
cultured with only culture supernatant of fibroblasts  stimulated with MDP at 50 ~g/ml 
incorporated 339 ±  66 cpm of [aH]TdR. 
TABLE II 
Thymocyte-activating Activity of the Culture Supernatants of Fibroblasts Stimulated 
with MDP and its Analogues 
Stimulants  Adjuvant  Concentration  [aH]TdR incorpora- 
activity  (~8/ml)  tion (Acpm -¢- SE)* 
Mur-NAc-e-Ala-n-isoGIn (MDP)  +  2  15,479 ±  1,713 
20  16,223 +  6,218 
100  14,759 ±  1,850 
Mur-NAc-L-Val-D-isoGln  +  2  15,304 ±  2,093 
20  14,429 ±  4,113 
Mur-NAc-L-Ser-D-isoGln  +  2  20,787 ±  1,277 
20  20,247 ±  2,825 
Mur-NAc-L-Ala-L-isoGln  --  2  481 ±  1,696 
20  2,007 ±  1,163 
Mur-NAe-t-Ala-o-isoAsn  -  2  5,458 ±  3,951 
20  2,155 ±  1,347 
* Acpm z  (cpm of culture added with the culture supernatant of MDP-stimulated fibroblasts)  - 
(cpm of culture added with the culture supernatant of nonstimulated fibrohlasts  to which MDP 
or its analogues were added at the end of culture). 
(Mur-NAc-L-Val-D-isoGln, Mur-NAc-L-Ser-D-isoGln) as well as the MDP effectively 
stimulated  fibroblasts  to  produce  thymocyte-activating  factor,  whereas  adjuvant- 
inactive  analogues  (Mur-NAc-L-Ala-L-isoGln,  Mur-NAc-L-Ala-D-isoAsn)  could  not 
stimulate  fibroblasts. Thus,  a  striking parallelism was found  between  the  adjuvant 
activity  of these  compounds  and  their  ability  to  stimulate  fibroblasts  to  produce 
thymocyte-activating factor. 
Enhanced  production  of thymocyte-activating factor by  MDP-stimulated  fibro- 
blasts was seen when they were cultured in the medium supplemented with FCS at 
concentrations of 1-10%, but not when cultured without FCS (data not shown). The 
culture supernatant of MDP-stimulated  fibroblasts incubated in the presence of 2% 
FCS was concentrated  and fractionated on a  Sephacryl S-200 column. As shown in 
Fig.  1,  the  thymocyte-activating factor  mainly  appeared  in  the  molecular  weight 
range of 30,000-60,000  with  a  major peak activity at  ~38,000.  Three lower peaks 
with activity were found in the molecular weight range of>60,000 and 10,000-30,000. 
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Fractionation of the  culture supernatant of MDP-stimulated  fibroblasts  on a  Sephacryl 
S-200  column.  The  supernatant  (200  ml)  of  fibroblasts  cultured  with  MDP  at  5  #g/ml  were 
concentrated and fractionated on a Sephacryl S-200 column in 0.5 M  NaCI, 0.1  M Tris-HCl buffer 
at pH 8.0.  Each fraction of the eluate was dialyzed and assayed for thymocyte-activating activity. 
Samples were tested at 20%  (vol/vol) concentration. Thymocyte-activating activity of the samples 
was expressed as Acpm [SH]TdR incorporation: Acpm =  cpm (thymocytes +  PHA +  sample) - 
cpm (thymocytes +  PHA). Arrows indicate the position where reference proteins were eluted from 
the same column: BSA, bovine serum albumin; EA, egg albumin; MG, whale myoglobin. 
stimulates the proliferation of PHA-indueed lymphoblasts. The culture supernatants 
of fibroblasts stimulated with or without MDP did not exhibit TCGF activity  (data 
not shown), suggesting that thymocyte-activating factor from MDP-stimulated  fibro- 
blasts is distinct from TCGF of the guinea pig that we described previously (15). 
Discussion 
A  synthetic adjuvant, MDP, was shown to stimulate  the guinea pig fibroblasts to 
produce thymocyte-activating factor for, to our knowledge, the first  time. The effect 
of MDP  that  may  be  carried  over  to  the  culture  supernatant  of MDP-stimulated 
fibroblasts  would be negligible,  since the control culture supernatant  of fibroblasts 
supplemented with MDP at the end of culture exhibited, after dialysis, activity only 2194  IRIBE ET AL.  BRIEF  DEFINITIVE REPORT 
as low as the supernatant of fibroblasts cultured without MDP. 
Macrophage-derived IL-1 has been shown to exhibit thymocyte-activating activity 
(16).  The  confluent  culture  of fibroblasts  used  in  our  study  consisted  of >99% 
fibroblasts  and  ~0.5%  nonspecific  esterase-positive cells.  If all  of the  nonspecific 
esterase-positive cells are macrophages, their concentration is estimated to be ~103 
cells/ml. At such low concentration the stimulating effect of MDP on the production 
of thymocyte-aetivating factor from macrophages would  not  be detected, because 
enhanced  production  of thymocyte-activating factor from  macrophages  by  MDP 
stimulation was shown when they were cultured at >105 cells/ml  (H. Iribe and T. 
Koga,  unpublished  data).  Furthermore,  thymocyte-activating factor  from  MDP- 
stimulated  fibroblasts was  mainly found in  the molecular weight  range of 30,000- 
60,000 by gel filtration, whereas T  ceil-activating monokines from guinea pig mae- 
rophages were found in two major fractions, one in the 50,000-90,000 mol wt fraction 
and the other in the 10,000-30,000 tool wt fraction (7, 8). These findings suggest that 
thymocyte-activating factor detected in  the supernatant  of MDP-stimulated  fibro- 
blasts is not macrophage-derived, but fibroblast-derived. 
Recently, it was shown that 3T3 fibroblasts stimulated with TPA released thymo- 
cyte-activating factors (12). These factors were found in two major fractions with peak 
activity at tool wt 30,000 and I0,000, respectively, by gel filtration (12). On the other 
hand,  thymocyte-activating factors  from  MDP-stimulated  fibroblasts  were  mainly 
found in the fraction of mol wt 30,000-60,000. It is not known whether this difference 
is due to the difference of stimulants used or the species difference. 
In this study, we showed that adjuvant-active analogues of MDP as well as MDP 
could stimulate fibroblasts to produce thymocyte-activating factor, whereas adjuvant- 
inactive analogues could not. Thus a  parallelism  was  found between the adjuvant 
activity  of these  compounds  and  the  ability  to  stimulate  fibroblasts  to  produce 
thymocyte-activating factor. Previously we also showed a striking parallelism between 
adjuvant activity of these compounds and the macrophage-stimulating effects on the 
production of T  cell-activating monokines (7). These findings suggest that in addition 
to the T  cell-activating monokine, fibroblast-derived factor contributes to the immu- 
nopotentiating effect of the MDP.  Furthermore, fibroblast-derived factor may play 
an important role in the immune response at the sites of chronic inflammation. 
Summary 
Synthetic muramyl dipeptide (MDP) could stimulate skin fibroblasts of the guinea 
pig to produce thymocyte-activating factor, which augments the proliferative response 
of thymocytes to phytohemagglutinin  (PHA).  Adjuvant-active analogues of MDP 
also stimulated fibroblasts to produce the factor, whereas adjuvant-inactive analogues 
failed to do so. Thus a  marked parallelism was found between adjuvant activity of 
these  compounds  and  the  stimulating  effect on  fibroblasts.  Thymocyte-activating 
factor derived from MDP-stimulated fibroblasts was found in the fraction of mol wt 
30,000-60,000 by gel filtration on a Sephacryl S-200 column. Furthermore, this factor 
did not exhibit T  cell growth factor activity. 
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